Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03935204Phase 2Completed
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Cervical CancerCondylomata Acuminata
PrincipalinvestigatorStart date: 2019-05-13
NCT03813940Phase 1Completed
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Cervical CancerCondylomata Acuminata
PrincipalinvestigatorStart date: 2019-01-03

Research Network

Collaboration Network

14 collaborators·13 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Jiangsu Provincial Centre for Disease Control and Prevention

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jun Zhang, master

Xiamen University

Related
12 trials

Shared therapeutic areas:

Condylomata AcuminataCancer of the Uterine Cervix

Worked with same sponsors:

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Xiamen Innovax Biotech Co., Ltd+1 more
Collaborated on 2 trials
Similarity Score28%

Juntao Ran

LanZhou University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaojie Ma

Affiliated Hospital of North Sichuan Medical College

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Xiaoying Xue

The Second Hospital of Hebei Medical University

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Kun Gao

Guangxi Medical University Cancer Center

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Dapeng Li

Shandong Cancer Hospital & Institute

Related
1 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Sandro Pignata, M.D., Ph.D.

National Cancer Institute, Naples

Related
9 trials

Shared therapeutic areas:

Cancer of the Uterine Cervix
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03935204Phase 2PrincipalInvestigator

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical CancerCondylomata Acuminata
Completed
NCT03813940Phase 1PrincipalInvestigator

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical CancerCondylomata Acuminata
Completed
NCT01263327Phase 1PrincipalInvestigator

Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Cancer
Completed

All 3 trials loaded